Background: It is unclear whether continuous positive airway pressure (CPAP), the treatment
of choice for severe obstructive sleep apnoea (OSA), is effective at improving outcomes in …

Background: Obstructive sleep apnoea syndrome (OSAS) affects an estimated 2–4% of the
middle aged population. Meta-analyses of randomised controlled trials have shown that the …

We evaluated factors associated with subjective and objective sleepiness at baseline and
after 6 months of continuous positive airway pressure (CPAP) therapy in patients with …

BACKGROUND: Continuous positive airway pressure (CPAP) is an effective treatment in
patients with moderate and severe sleep apnoea/hypopnoea syndrome (SAHS), but the …

Rationale: Twenty-eight percent of people with mild to moderate obstructive sleep apnea
experience daytime sleepiness, which interferes with daily functioning. It remains unclear …

Background Previous studies have shown conflicting results on the effect of continuous
positive airway pressure (CPAP) on quality of life (QoL) in obstructive sleep apnoea (OSA) …

Background: The simplest method of initiating and maintaining therapeutic continuous
positive airways pressure (CPAP) therapy for obstructive sleep apnoea (OSA) has not been …

Study objectives Continuous positive airway pressure (CPAP) therapy has become the
treatment of choice for obstructive sleep apnea (OSA). However, the efficacy of CPAP …

Study objectives To determine the short-term and long-term impacts of continuous positive
airway pressure (CPAP) therapy on health-related quality of life (HRQL) in patients with …

Background Although continuous positive airway pressure (CPAP) has become the first line
of therapy for obstructive sleep apnea (OSA), it remains controversial whether non-sleepy …